NCT02993731 2023-11-15CanStem111PSumitomo Pharma America, Inc.Phase 3 Completed1,134 enrolled 18 charts
NCT04299880 2023-11-08Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsSumitomo Pharma America, Inc.Phase 1 Completed7 enrolled
NCT01088815 2019-04-26Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed98 enrolled 14 charts